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(FGF: fibroblast growth factor; TGF-β: transforming growth factor beta; BMP: bone morphogenic protein; PKA, PKC: protein kinase A and C; PP2A and PP2B: phosphoprotein phosphatase 2A and 2B; ERK1/2: extracellular signal regulated kinase; JNK: c-jun N-terminal kinase; CREB: cAMP-responsive element binding protein; NFAT: nuclear factor of activated T-lymphocytes). . Tandem C1 domains (C1A and C1B) are molecular sensors of PMA/DAG in cPKC and nPKC isoforms, whereas the single aPKC C1 domain does not bind DAG/PMA. Phox/Bem domain 1 (PB1; in dark blue) acts as a dimerisation site with various proteins. Homology region 1 (HR1; in light blue) that is only present in PKN confers small-GTPase binding properties. PKCs are regulated by autoinhibition through their pseudosubstrate sites (PS; in ultramarine) that binds to the substrate-binding pocket in the C4 kinase domain (in purple). When the regulatory domain is recruited to the plasma membrane through Ca 2+ , phospholipid and DAG, autoinhibition is relieved. Adapted from [25] and [26] . and co-workers attempted to confirm the role of PKC during digit 
through a PKC-independent pathway to enhance in vitro chondrogenesis 449 has been unequivocally confirmed. 
bud-derived micromass cultures and described it as an important posi- Western blotting revealed that primary chondrocytes expressed PKC subtypes α, γ, δ, ι and λ, whereas only PKCα, ι, λ and ε were identified in C-20/A4 cells. Role of PKCα in mechanotransduction pathways.
[50] modulating the expression of key adhesion molecules [68] .
759
The results of our laboratory suggest that the novel PKC isoform suggested that the ERK-1 pathway alone was insufficient for inducing 787 chondrogenesis and other pathways were also involved.
788
As it was discussed earlier, Nurminsky and co-workers found a close 
PKC, p38 MAPK and chondrogenesis

805
The increased expression and activity of PKC are required for down- ling appeared to be independent of p38 MAP kinase signalling.
827
To further dissect the molecular mechanism of PKC-mediated MAPK Rottmar and colleagues [64] . Fig. 7 shows a schematic pathway of the in-
863
volvement of PKC and p38 MAPK signalling during chondrogenesis. control chondrocyte dedifferentiation [74] .
887
The relationship between PKC signalling and p38 MAPK has been 
902
If we consider the fact that chondrocyte de-and redifferentiation also . PKC signalling is involved in activating the p38 MAPK pathway to enhance chondrogenesis. TGF-β3 stimulates chondrogenic differentiation through upregulation of Wnt5-a, which in turn activates the PKCα-p38 pathway. Disruption of the actin cytoskeleton by cytochalasin D can also activate the p38 MAPK pathway in a PKCα dependent manner. Note that the PKC-p38 MAPK pathway is reported to regulate the induction of chondrogenesis by disruption of the cytoskeleton, unlike micromass culture-induced chondrogenesis when p38 is independent of PKC signalling. Similarly, rapamycin suppressed chondrogenesis via a p38 independent mechanism. For more detailed explanation and relevant references, please see text. (SB203580 and PD169316, p38 MAPK inhibitors).
these effects could be blocked by the application of the EGF receptor 940 inhibitor AG1478 [77] . Since selective inhibition of PKCα was sufficient cultures prepared from chick embryonic mesenchyme [65] . In contrast,
962
Hwang and co-workers described that Wnt-3a caused the expression of 
965
In chondrocytes, the effects of CCN2/connective tissue growth factor
966
(CCN2/CTGF) are known to promote both proliferation and differentia-967 tion of chondrocytes via the ERK1/2, p38 and JNK MAPK pathways [78] .
968
In terms of upstream kinases of this pathway, the involvement of on the activation of p38 and ERK1/2, it had no effect on JNK activation, 974 which suggests that while PKC was shown to be the major secondary 975 messenger of CCN2-mediated signals, the PKC-p38 pathway was inde-976 pendent of JNK signalling [78] .
977
In contrast, based on the results of Kim and colleagues, a link could 978 be established between PKC and JNK signalling in chondrocytes [10] .
979
They used a different approach: microRNAs (miRNAs). These small tinued. As mentioned above, the PKA pathway has long been established 1000 to be a positive regulator of in vitro chondrogenesis [79] . selective inhibition of PKCs did not affect PKA activity (see Fig. 10 ).
1009
As mentioned previously, PKC was involved in mediating the effects 1010 of glucose concentration in culture medium [68] . Since the glucose concentrations of glucose [80] . In that study, MSCs maintained in high 1015 glucose were less chondrogenic than low glucose maintained cells. U
prevented the development of the disease; furthermore, they also 1137 provided evidence that PKC was involved in the stress-mediated degra-1138 dation of articular cartilage [84] .
1139
In contrast to these initial results, LaVallie and co-workers demon- thoroughly investigated [95] . Furthermore, Ca 2+ dependent signalling pathways are also key factors that govern chondrogenesis [96] . 
